Differential	differential	O	O
modulation	modulation	O	O
by	by	O	O
estrogen	estrogen	S_chemical	O
of	of	O	O
alpha2-adrenergic	alpha2-adrenergic	O	O
and	and	O	O
I1-imidazoline	i1-imidazoline	O	O
receptor-mediated	receptor-mediated	O	O
hypotension	hypotension	O	S_disease
in	in	O	O
female	female	O	O
rats	rats	O	O
.	.	O	O

We	we	O	O
have	have	O	O
recently	recently	O	O
shown	shown	O	O
that	that	O	O
estrogen	estrogen	S_chemical	O
negatively	negatively	O	O
modulates	modulates	O	O
the	the	O	O
hypotensive	hypotensive	O	S_disease
effect	effect	O	O
of	of	O	O
clonidine	clonidine	S_chemical	O
(	(	O	O
mixed	mixed	O	O
alpha2-/I1-receptor	alpha2-/i1-receptor	O	O
agonist	agonist	O	O
)	)	O	O
in	in	O	O
female	female	O	O
rats	rats	O	O
and	and	O	O
implicates	implicates	O	O
the	the	O	O
cardiovascular	cardiovascular	O	O
autonomic	autonomic	O	O
control	control	O	O
in	in	O	O
this	this	O	O
interaction	interaction	O	O
.	.	O	O

The	the	O	O
present	present	O	O
study	study	O	O
investigated	investigated	O	O
whether	whether	O	O
this	this	O	O
effect	effect	O	O
of	of	O	O
estrogen	estrogen	S_chemical	O
involves	involves	O	O
interaction	interaction	O	O
with	with	O	O
alpha2-	alpha2-	S_chemical	O
and/or	and/or	O	O
I1-receptors	i1-receptors	O	O
.	.	O	O

Changes	changes	O	O
evoked	evoked	O	O
by	by	O	O
a	a	O	O
single	single	O	O
intraperitoneal	intraperitoneal	O	O
injection	injection	O	O
of	of	O	O
rilmenidine	rilmenidine	S_chemical	O
(	(	O	O
600	600	O	O
microg/kg	microg/kg	O	O
)	)	O	O
or	or	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
(	(	O	O
100	100	O	O
mg/kg	mg/kg	O	O
)	)	O	O
,	,	O	O
selective	selective	O	O
I1-	i1-	S_chemical	O
and	and	O	O
alpha2-receptor	alpha2-receptor	O	O
agonists	agonists	O	O
,	,	O	O
respectively	respectively	O	O
,	,	O	O
in	in	O	O
blood	blood	O	O
pressure	pressure	O	O
,	,	O	O
hemodynamic	hemodynamic	O	O
variability	variability	O	O
,	,	O	O
and	and	O	O
locomotor	locomotor	O	O
activity	activity	O	O
were	were	O	O
assessed	assessed	O	O
in	in	O	O
radiotelemetered	radiotelemetered	O	O
sham-operated	sham-operated	O	O
and	and	O	O
ovariectomized	ovariectomized	O	O
(	(	O	O
Ovx	ovx	O	O
)	)	O	O
Sprague-Dawley	sprague-dawley	O	O
female	female	O	O
rats	rats	O	O
with	with	O	O
or	or	O	O
without	without	O	O
12-wk	12-wk	O	O
estrogen	estrogen	S_chemical	O
replacement	replacement	O	O
.	.	O	O

Three	three	O	O
time	time	O	O
domain	domain	O	O
indexes	indexes	O	O
of	of	O	O
hemodynamic	hemodynamic	O	O
variability	variability	O	O
were	were	O	O
employed	employed	O	O
:	:	O	O
the	the	O	O
standard	standard	O	O
deviation	deviation	O	O
of	of	O	O
mean	mean	O	O
arterial	arterial	O	O
pressure	pressure	O	O
as	as	O	O
a	a	O	O
measure	measure	O	O
of	of	O	O
blood	blood	O	O
pressure	pressure	O	O
variability	variability	O	O
and	and	O	O
the	the	O	O
standard	standard	O	O
deviation	deviation	O	O
of	of	O	O
beat-to-beat	beat-to-beat	O	O
intervals	intervals	O	O
(	(	O	O
SDRR	sdrr	O	O
)	)	O	O
and	and	O	O
the	the	O	O
root	root	O	O
mean	mean	O	O
square	square	O	O
of	of	O	O
successive	successive	O	O
differences	differences	O	O
in	in	O	O
R-wave-to-R-wave	r-wave-to-r-wave	O	O
intervals	intervals	O	O
as	as	O	O
measures	measures	O	O
of	of	O	O
heart	heart	O	O
rate	rate	O	O
variability	variability	O	O
.	.	O	O

In	in	O	O
sham-operated	sham-operated	O	O
rats	rats	O	O
,	,	O	O
rilmenidine	rilmenidine	S_chemical	O
or	or	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
elicited	elicited	O	O
similar	similar	O	O
hypotension	hypotension	O	S_disease
that	that	O	O
lasted	lasted	O	O
at	at	O	O
least	least	O	O
5	5	O	O
h	h	S_chemical	O
and	and	O	O
was	was	O	O
associated	associated	O	B_disease
with	with	O	I_disease
reductions	reductions	O	O
in	in	O	O
standard	standard	O	O
deviation	deviation	O	O
of	of	O	O
mean	mean	O	O
arterial	arterial	O	O
pressure	pressure	O	O
.	.	O	O

SDRR	sdrr	O	O
was	was	O	O
reduced	reduced	O	O
only	only	O	O
by	by	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
.	.	O	O

Ovx	ovx	O	O
significantly	significantly	O	O
enhanced	enhanced	O	O
the	the	O	O
hypotensive	hypotensive	O	S_disease
response	response	O	O
to	to	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
,	,	O	O
in	in	O	O
contrast	contrast	O	O
to	to	O	O
no	no	O	O
effect	effect	O	O
on	on	O	O
rilmenidine	rilmenidine	S_chemical	O
hypotension	hypotension	O	S_disease
.	.	O	O

The	the	O	O
enhanced	enhanced	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
hypotension	hypotension	O	S_disease
in	in	O	O
Ovx	ovx	O	O
rats	rats	O	O
was	was	O	O
paralleled	paralleled	O	O
with	with	O	O
further	further	O	O
reduction	reduction	O	O
in	in	O	O
SDRR	sdrr	O	O
and	and	O	O
a	a	O	O
reduced	reduced	O	O
locomotor	locomotor	O	O
activity	activity	O	O
.	.	O	O

Estrogen	estrogen	S_chemical	O
replacement	replacement	O	O
(	(	O	O
17beta-estradiol	17beta-estradiol	S_chemical	O
subcutaneous	subcutaneous	O	O
pellet	pellet	O	O
,	,	O	O
14.2	14.2	O	O
microg/day	microg/day	O	O
,	,	O	O
12	12	O	O
wk	wk	O	O
)	)	O	O
of	of	O	O
Ovx	ovx	O	O
rats	rats	O	O
restored	restored	O	O
the	the	O	O
hemodynamic	hemodynamic	O	O
and	and	O	O
locomotor	locomotor	O	O
effects	effects	O	O
of	of	O	O
alpha-methyldopa	alpha-methyldopa	S_chemical	O
to	to	O	O
sham-operated	sham-operated	O	O
levels	levels	O	O
.	.	O	O

These	these	O	O
findings	findings	O	O
suggest	suggest	O	O
that	that	O	O
estrogen	estrogen	S_chemical	O
downregulates	downregulates	O	O
alpha2-	alpha2-	S_chemical	O
but	but	O	O
not	not	O	O
I1-receptor-mediated	i1-receptor-mediated	O	O
hypotension	hypotension	O	S_disease
and	and	O	O
highlight	highlight	O	O
a	a	O	O
role	role	O	O
for	for	O	O
the	the	O	O
cardiac	cardiac	O	O
autonomic	autonomic	O	O
control	control	O	O
in	in	O	O
alpha-methyldopa-estrogen	alpha-methyldopa-estrogen	O	O
interaction	interaction	O	O
.	.	O	O

